FGL1 and cancer: Additionally, FGL-1 is the main immune ligand of lymphocyte-activation gene 3 (LAG-3) that negatively regulates T cells’ activation and plays a vital role in hepatocyte regeneration, glucose and lipid metabolism, as well as serving as a potential target for cancer immunotherapy [25,26,27].